Welcome to our dedicated page for JBS N.V. SEC filings (Ticker: JBS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
JBS N.V. filings document the reporting of a foreign private issuer with common shares listed on the NYSE and Brazilian depositary receipts referenced in shareholder materials. The record includes Form 6-K current reports, Form 20-F annual-report notices, audited consolidated financial statements, IFRS operating results, liquidity and capital resources, capital-structure information and dividend disclosures.
JBS filing exhibits also cover annual general meeting materials, shareholder voting results, board composition matters, director reappointments, adoption of annual accounts and discussion of the Dutch Corporate Governance Code. Investor presentations and earnings releases describe the company's global protein operations, reportable segments, forward-looking statement assumptions and financial performance across its food production and branded product portfolio.
Capital Research Global Investors filed a Schedule 13G reporting beneficial ownership of 5.4% of JBS N.V. common stock, equal to 43,903,609 shares, with the event date 09/30/2025.
The filer reports sole voting power over 43,758,295 shares and sole dispositive power over 43,903,609 shares. The filing notes that the stake includes 43,758,257 Depositary Receipts, each representing one common share, and references 814,216,001 shares believed outstanding. The securities are stated to be held in the ordinary course of business and not for the purpose of changing or influencing control.
JBS N.V., a company organized under the laws of the Netherlands, filed a Form S-8 registration statement to register securities issued under the JBS N.V. Incentive Plan. The filing incorporates by reference the company’s future reports under the Exchange Act so that ongoing disclosures automatically update the information available to plan participants. It also details how directors and officers may be indemnified under Dutch law for certain legal costs and liabilities, while noting the SEC’s position that indemnification for Securities Act liabilities is unenforceable. The document includes standard undertakings to update or deregister securities through post-effective amendments and is signed by senior executives and board members, including the chief executive officer and chief financial officer.
BNDES Participacoes S.A. (BNDESPAR) and Banco Nacional de Desenvolvimento Economico e Social (BNDES) disclosed shared beneficial ownership of 201,676,700 Class A common shares of JBS N.V., equal to 24.77% of the outstanding Class A shares (based on 814,216,001 Class A shares outstanding as of July 2, 2025). The filing states the reported shares are directly owned by BNDESPAR, a wholly owned subsidiary of BNDES, and that voting and disposition decisions are made by BNDESPAR’s Board of Executive Officers. The reporting persons hold 0 sole voting or dispositive power and 201,676,700 shared voting and dispositive power. Because JBS has dual-class shares, the reported position represents 5.36% of total outstanding voting power when Class B shares (ten votes each) are included.
Reporting persons jointly disclose beneficial ownership of 536,076,699 JBS N.V. shares, representing 48.3% of the class. The Schedule 13G is filed jointly by Wesley Mendonca Batista, Joesley Mendonca Batista, J&F S.A. and J&F Investments Luxembourg S.a r.l. The filing states that 241,234,515 are Class A common shares and 294,842,184 are Class B common shares held by J&F Investments Luxembourg S.a r.l. Each Class B share is convertible into one Class A share at the holder's option and carries ten votes per share; for the percentage calculation the Class B shares are treated as converted into Class A shares. The Reporting Persons share voting and dispositive power over the 536,076,699 shares and the filing discloses that Wesley and Joesley Mendonca Batista indirectly own 100% of J&F S.A. and equally share voting and investment powers. Exhibit 99.1 is a joint filing agreement and signatures are provided by the reporting parties.